- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 144,307,555
- Total 13F shares
- 141,285,706
- Share change
- -6,310,994
- Total reported value
- $5,088,913,432
- Put/Call ratio
- 28%
- Price per share
- $36.02
- Number of holders
- 282
- Value change
- -$216,599,261
- Number of buys
- 134
- Number of sells
- 146
Quarterly Holders Quick Answers
What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92243G108:
Top shareholders of PCVX - Vaxcyte, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
10%
from 13D/G
|
14,691,344
|
$477,656,211 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
|
Company |
9.9%
|
12,964,491
|
$426,531,754 | $0 | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
8.4%
|
12,151,050
|
$395,030,620 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.3%
|
11,997,085
|
$390,025,233 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
10,642,243
|
$345,979,336 | — | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
4.2%
|
6,001,124
|
$195,097,000 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.4%
|
4,954,804
|
$161,080,679 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
4,942,235
|
$160,672,060 | — | 30 Jun 2025 | |
| Capital Research Global Investors |
13F
|
Company |
3.3%
|
4,771,786
|
$155,130,763 | — | 30 Jun 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.3%
|
3,372,837
|
$109,650,931 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.2%
|
3,170,247
|
$103,066,000 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.1%
|
3,088,450
|
$100,405,509 | — | 30 Jun 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
2.1%
|
3,071,588
|
$99,857,326 | — | 30 Jun 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.1%
|
3,068,898
|
$99,769,874 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
3,011,140
|
$97,903,448 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
1.5%
|
2,150,000
|
$69,896,500 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.98%
|
1,417,711
|
$46,089,785 | — | 30 Jun 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.97%
|
1,399,299
|
$45,491,210 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.96%
|
1,380,853
|
$44,891,531 | — | 30 Jun 2025 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
0.91%
|
1,310,605
|
$42,607,769 | — | 30 Jun 2025 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.9%
|
1,305,125
|
$42,429,614 | — | 30 Jun 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.9%
|
1,298,514
|
$42,214,690 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.83%
|
1,198,770
|
$38,972,014 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.81%
|
1,175,661
|
$38,226,152 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.78%
|
1,121,892
|
$36,472,710 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.77%
|
1,104,839
|
$35,918,316 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.76%
|
1,090,738
|
$35,459,892 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.75%
|
1,082,671
|
$35,197,634 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
0.68%
|
987,674
|
$32,109,282 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.65%
|
939,275
|
$30,535,842 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
934,668
|
$30,386,056 | — | 30 Jun 2025 | |
| Novo Holdings A/S |
13F
|
Company |
0.63%
|
916,160
|
$29,784,362 | — | 30 Jun 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
848,141
|
$27,573,294 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.58%
|
841,922
|
$27,370,915 | — | 30 Jun 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.57%
|
825,795
|
$26,846,595 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.56%
|
809,530
|
$26,317,820 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.52%
|
749,392
|
$24,363,000 | — | 30 Jun 2025 | |
| Jeff Fairman |
3/4/5
|
VP, Research |
—
mixed-class rows
|
369,054
mixed-class rows
|
$22,935,618 | — | 30 Dec 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.45%
|
646,055
|
$21,003,236 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.44%
|
640,885
|
$20,835,171 | — | 30 Jun 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
633,204
|
$20,585,462 | — | 30 Jun 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.4%
|
571,939
|
$18,593,737 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.38%
|
555,008
|
$18,043,312 | — | 30 Jun 2025 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.38%
|
544,221
|
$17,692,625 | — | 30 Jun 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.37%
|
539,784
|
$17,548,378 | — | 30 Jun 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.37%
|
532,203
|
$17,301,920 | — | 30 Jun 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.35%
|
512,135
|
$16,649,000 | — | 30 Jun 2025 | |
| TWINBEECH CAPITAL LP |
13F
|
Company |
0.35%
|
503,248
|
$16,360,592 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.34%
|
487,769
|
$15,857,370 | — | 30 Jun 2025 | |
| COMERICA BANK |
13F
|
Company |
0.33%
|
479,510
|
$15,588,872 | — | 30 Jun 2025 |
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q3 2025
As of 30 Sep 2025,
Vaxcyte, Inc. - COMMON STOCK (PCVX) was held by
282 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
141,285,706 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, FMR LLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, D. E. Shaw & Co., Inc., and Paradigm Biocapital Advisors LP.
This page lists
282
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
292
Q3 2025 holders
282
Holder diff
-10
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.